Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction

NCT00661700 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00661700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00661700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2003
Completion date
May 31, 2004
Enrollment
611 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction